A Detailed Analysis of the Expectorant Drugs Market Based on Initiatives by Both Governments and Market Players, Faster FDA Approvals, and Continuous Innovation in Respiratory Care Pharmaceuticals
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 178
Report ID: PMRREP33736
1. Executive Summary
1.1. Global Expectorant Drugs Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Drug Type Lifecycle Analysis
2.4. Expectorant Drugs Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Expectorant Drugs Market Outlook: Drug Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
3.3.3.1. Secretion Enhancer
3.3.3.1.1. Potassium Citrate
3.3.3.1.2. Potassium Iodide
3.3.3.1.3. Sodium Citrate
3.3.3.1.4. Guaiphenesin
3.3.3.1.5. Ammonium Chloride
3.3.3.1.6. Others
3.3.3.2. Mucolytics
3.3.3.2.1. Bromhexine
3.3.3.2.2. Ambroxol
3.3.3.2.3. Acetyl Cysteine
3.3.3.2.4. Carbocisteineurine
3.4. Market Attractiveness Analysis: Drug Type
3.5. Global Expectorant Drugs Market Outlook: Dosage Form
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Dosage Form, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
3.5.3.1. Oral Solid
3.5.3.2. Oral Liquid
3.5.3.3. Inhalant
3.6. Market Attractiveness Analysis: Dosage Form
3.7. Global Expectorant Drugs Market Outlook: Product Type
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.7.3.1. Over-The-Counter (OTC)
3.7.3.2. Prescription Drug
3.8. Market Attractiveness Analysis: Product Type
3.9. Global Expectorant Drugs Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.9.3.1. Hospital Pharmacies
3.9.3.2. Retail store
3.9.3.3. Drug store
3.9.3.4. Online Pharmacies
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global Expectorant Drugs Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Drug Type
5.3.3. By Dosage Form
5.3.4. By Product Type
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
5.5.1. Secretion Enhancer
5.5.1.1. Potassium Citrate
5.5.1.2. Potassium Iodide
5.5.1.3. Sodium Citrate
5.5.1.4. Guaiphenesin
5.5.1.5. Ammonium Chloride
5.5.1.6. Others
5.5.2. Mucolytics
5.5.2.1. Bromhexine
5.5.2.2. Ambroxol
5.5.2.3. Acetyl Cysteine
5.5.2.4. Carbocisteineurine
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
5.6.1. Oral Solid
5.6.2. Oral Liquid
5.6.3. Inhalant
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.7.1. Over-The-Counter (OTC)
5.7.2. Prescription Drug
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.8.1. Hospital Pharmacies
5.8.2. Retail store
5.8.3. Drug store
5.8.4. Online Pharmacies
5.9. Market Attractiveness Analysis
6. Europe Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Drug Type
6.3.3. By Dosage Form
6.3.4. By Product Type
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
6.5.1. Secretion Enhancer
6.5.1.1. Potassium Citrate
6.5.1.2. Potassium Iodide
6.5.1.3. Sodium Citrate
6.5.1.4. Guaiphenesin
6.5.1.5. Ammonium Chloride
6.5.1.6. Others
6.5.2. Mucolytics
6.5.2.1. Bromhexine
6.5.2.2. Ambroxol
6.5.2.3. Acetyl Cysteine
6.5.2.4. Carbocisteineurine
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
6.6.1. Oral Solid
6.6.2. Oral Liquid
6.6.3. Inhalant
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.7.1. Over-The-Counter (OTC)
6.7.2. Prescription Drug
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.8.1. Hospital Pharmacies
6.8.2. Retail store
6.8.3. Drug store
6.8.4. Online Pharmacies
6.9. Market Attractiveness Analysis
7. East Asia Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Drug Type
7.3.3. By Dosage Form
7.3.4. By Product Type
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
7.5.1. Secretion Enhancer
7.5.1.1. Potassium Citrate
7.5.1.2. Potassium Iodide
7.5.1.3. Sodium Citrate
7.5.1.4. Guaiphenesin
7.5.1.5. Ammonium Chloride
7.5.1.6. Others
7.5.2. Mucolytics
7.5.2.1. Bromhexine
7.5.2.2. Ambroxol
7.5.2.3. Acetyl Cysteine
7.5.2.4. Carbocisteineurine
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
7.6.1. Oral Solid
7.6.2. Oral Liquid
7.6.3. Inhalant
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.7.1. Over-The-Counter (OTC)
7.7.2. Prescription Drug
7.8. Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.8.1. Hospital Pharmacies
7.8.2. Retail store
7.8.3. Drug store
7.8.4. Online Pharmacies
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Drug Type
8.3.3. By Dosage Form
8.3.4. By Product Type
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
8.5.1. Secretion Enhancer
8.5.1.1. Potassium Citrate
8.5.1.2. Potassium Iodide
8.5.1.3. Sodium Citrate
8.5.1.4. Guaiphenesin
8.5.1.5. Ammonium Chloride
8.5.1.6. Others
8.5.2. Mucolytics
8.5.2.1. Bromhexine
8.5.2.2. Ambroxol
8.5.2.3. Acetyl Cysteine
8.5.2.4. Carbocisteineurine
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
8.6.1. Oral Solid
8.6.2. Oral Liquid
8.6.3. Inhalant
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.7.1. Over-The-Counter (OTC)
8.7.2. Prescription Drug
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.8.1. Hospital Pharmacies
8.8.2. Retail store
8.8.3. Drug store
8.8.4. Online Pharmacies
8.9. Market Attractiveness Analysis
9. Latin America Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Drug Type
9.3.3. By Dosage Form
9.3.4. By Product Type
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
9.5.1. Secretion Enhancer
9.5.1.1. Potassium Citrate
9.5.1.2. Potassium Iodide
9.5.1.3. Sodium Citrate
9.5.1.4. Guaiphenesin
9.5.1.5. Ammonium Chloride
9.5.1.6. Others
9.5.2. Mucolytics
9.5.2.1. Bromhexine
9.5.2.2. Ambroxol
9.5.2.3. Acetyl Cysteine
9.5.2.4. Carbocisteineurine
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
9.6.1. Oral Solid
9.6.2. Oral Liquid
9.6.3. Inhalant
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.7.1. Over-The-Counter (OTC)
9.7.2. Prescription Drug
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.8.1. Hospital Pharmacies
9.8.2. Retail store
9.8.3. Drug store
9.8.4. Online Pharmacies
9.9. Market Attractiveness Analysis
10. Middle East & Africa Expectorant Drugs Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Drug Type
10.3.3. By Dosage Form
10.3.4. By Product Type
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Type, 2023 - 2030
10.5.1. Secretion Enhancer
10.5.1.1. Potassium Citrate
10.5.1.2. Potassium Iodide
10.5.1.3. Sodium Citrate
10.5.1.4. Guaiphenesin
10.5.1.5. Ammonium Chloride
10.5.1.6. Others
10.5.2. Mucolytics
10.5.2.1. Bromhexine
10.5.2.2. Ambroxol
10.5.2.3. Acetyl Cysteine
10.5.2.4. Carbocisteineurine
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Dosage Form, 2023 - 2030
10.6.1. Oral Solid
10.6.2. Oral Liquid
10.6.3. Inhalant
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.7.1. Over-The-Counter (OTC)
10.7.2. Prescription Drug
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.8.1. Hospital Pharmacies
10.8.2. Retail store
10.8.3. Drug store
10.8.4. Online Pharmacies
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Potassium Citrate
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Abbott Laboratories
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Acella Pharmaceuticals LLC
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Astrazeneca Plc.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Cipla Limited
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Dabur India Ltd
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Glenmark Pharmaceuticals Limited
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Johnson and Johnson
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Merck KGaA
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Novartis International AG
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Pfizer Inc.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Proctor and Gamble Co
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
